Latest Disclosure Policy News

Terra Critical Minerals has clarified that its recent share price jump is tied to soaring tungsten prices and its acquisition of a key US tungsten project. The company confirms compliance with ASX disclosure rules amid heightened market interest.

Beetaloo Energy has responded to ASX concerns over a delayed disclosure of a director's change in interest, attributing it to an administrative oversight and pledging enhanced compliance measures.

Paterson Resources has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information is driving the recent market activity.

Vinyl Group Limited has responded to ASX concerns after confidential details of its Val Morgan Digital acquisition leaked prematurely to the media, prompting a review of its disclosure controls.

QEM Limited confirms a $1.442 million capital raising via placement, addressing ASX queries on disclosure timing and compliance. The company clarifies board approvals and trading halt details, reinforcing its adherence to continuous disclosure obligations.

BPM Minerals has responded to ASX scrutiny over the timing and materiality of its Bonnie & Clyde tenement grant announcement and related capital raising, confirming adherence to continuous disclosure rules.

Klevo Rewards Ltd has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to administrative timing issues and pledging enhanced compliance measures.

Bubalus Resources has responded to ASX concerns over a delayed director interest notice, attributing the lapse to an administrative oversight and reaffirming its commitment to compliance.

Manuka Resources has affirmed the material significance of a draft decision by New Zealand’s EPA declining consent for its Taranaki VTM Project, clarifying its disclosure timeline and compliance with ASX rules amid recent share price volatility.

EMC Gold has responded to an ASX price query following a sudden spike in its share price, confirming no undisclosed information exists and affirming compliance with continuous disclosure rules.

Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.

Askari Metals has addressed an ASX query regarding the late filing of a director's securities interest notice, attributing the delay to awaiting regulatory guidance following an inadvertent related party securities breach.